Introduced in House — H.R. 8000

119th CONGRESS

2d Session

H. R. 8000

IN THE HOUSE OF REPRESENTATIVES

March 19, 2026

Mr. Bilirakis introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend the Controlled Substances Act to schedule synthetic 7-hydroxymitragynine as a Schedule I controlled substance.

Section 1. Short title

This Act may be cited as the End Needless Distribution of 7-OH Act or the END 7-OH Act.

Sec. 2. Scheduling of 7-hydroxymitragynine

Schedule I, as set forth in section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)), is amended by adding at the end of subsection (b) of such schedule the following:

(23)
7-hydroxymitragynine—
(A)
including its synthetic equivalents; but
(B)
not including 7-hydroxymitragynine naturally contained in the plant of the genus and species name: Mitragyna speciosa Korth, also known as kratom.